Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation

Background: The pharmacological cardioversion of recent-onset atrial fibrillation (AF) is a challenge for the clinician. The aim of the study was to compare the efficacy, the safety, and the overall cost of intravenous (iv) administration of vernakalant, which is a relatively new atrial-selective an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hippokratia
Egile Nagusiak: Vogiatzis, I, Papavasiliou, E, Dapcevitch, I, Pittas, S, Koulouris, E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239091/
https://ncbi.nlm.nih.gov/pubmed/30455558
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak